Premium
MicroRNA profiling of multiple osteochondromas: identification of disease‐specific and normal cartilage signatures
Author(s) -
Zuntini M,
Salvatore M,
Pedrini E,
Parra A,
Sgariglia F,
Magrelli A,
Taruscio D,
Sangiorgi L
Publication year - 2010
Publication title -
clinical genetics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.543
H-Index - 102
eISSN - 1399-0004
pISSN - 0009-9163
DOI - 10.1111/j.1399-0004.2010.01490.x
Subject(s) - osteochondroma , microrna , cartilage , hereditary multiple exostoses , chondrosarcoma , phenotype , biology , pathogenesis , gene expression profiling , disease , cancer research , pathology , pathological , malignant transformation , gene , bioinformatics , genetics , medicine , gene expression , anatomy
Zuntini M, Salvatore M, Pedrini E, Parra A, Sgariglia F, Magrelli A, Taruscio D, Sangiorgi L. MicroRNA profiling of Multiple Osteochondromas: identification of disease‐specific and normal cartilage signatures. Multiple osteochondroma (MO) is a rare skeletal disease characterized by the formation of multiple benign cartilage‐capped bone tumors; in 1–5% of patients, a malignant transformation into peripheral chondrosarcoma may occur. This disorder is characterized by a large spectrum of germline mutations scattered along EXT1/EXT2 genes, the presence of a significant percentage of patients without alterations in EXT genes, and a large phenotypic variability. The molecular basis of MO genetic and clinical heterogeneity, including the causes underlying malignant transformation, is currently unknown. This leads to the lack of appropriate diagnostic/prognostic markers as well as of therapeutic options. Recently, specific microRNAs (miRNAs) were reported to be involved in chondrogenesis and inflammatory cartilage diseases. We therefore hypothesized a role for microRNAs in cartilaginous tumors and investigated microRNA expression in osteochondroma and normal cartilage tissues to evaluate whether they could affect osteochondromas onset and/or clinical manifestations. Our results indicate that miRNAs differentially expressed in MO samples may hamper the molecular signaling responsible for normal differentiation of chondrocytes, contributing to pathogenesis and clinical outcome. Although further studies are needed to validate our observations and to identify targets of miRNAs, this is the first study reporting on miRNA expression in growth plate and its comparison with pathological conditions.